Tolvact-15 Tablet

Tolvaptan 15 mg — V2 Antagonist (Vaptan)

Tolvact-15 Tablet — Tolvaptan 15 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Tolvaptan 15 mg
Dosage Form Tablet
Pack Type Box
Pack Size 10 x 4 (Alu-Alu)
MRP ₹ 4500
Therapy Nephrology — Selective vasopressin V2 receptor antagonist
Storage Store below 25°C.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Tolvact-15 Tablet

Tolvact-15 Tablet contains Tolvaptan 15 mg, a selective vasopressin V2 receptor antagonist. It produces aquaresis — water excretion without sodium loss — making it uniquely useful in dilutional hyponatraemia.

Indicated for euvolaemic and hypervolaemic hyponatraemia (SIADH, cirrhotic ascites, heart failure) and autosomal dominant polycystic kidney disease (ADPKD) — TEMPO 3:4 trial.

Camrut Healthcare manufactures Tolvact-15 under WHO-GMP conditions for PCD pharma franchise across India.

Indications

  • Euvolaemic hyponatraemia (SIADH)
  • Hypervolaemic hyponatraemia (heart failure, cirrhotic ascites)
  • Autosomal dominant polycystic kidney disease (ADPKD)

Mechanism of Action

Tolvaptan selectively blocks V2 vasopressin receptors in renal collecting ducts, preventing insertion of aquaporin-2 water channels. This produces selective water excretion (aquaresis) without sodium loss — correcting dilutional hyponatraemia. In ADPKD it reduces cyst growth via reduced cAMP.

Dosage & Administration

['Hyponatraemia: Start 15 mg once daily under hospital supervision', 'Titrate to max 60 mg/day', 'ADPKD: split-dose regimen (45 mg + 15 mg / 60 mg + 30 mg / 90 mg + 30 mg)', 'Initiate only in hospital with sodium monitoring']

Side Effects

['Thirst, polyuria, dry mouth (predictable, dose-related)', 'Hepatotoxicity (with ADPKD use; black-box warning)', 'Rapid sodium correction (osmotic demyelination risk)', 'Hyperglycaemia']

Contraindications & Precautions

['Hypovolaemic hyponatraemia', 'Anuria', 'Severe hepatic impairment (with ADPKD)', 'Concurrent strong CYP3A4 inhibitors', 'Pregnancy and breastfeeding']

Storage

Store below 25°C.

PCD Pharma Franchise & Third-Party Manufacturing
Tolvact-15 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.